Browsing Tag
investor relations partnership
1 post
Rakovina Therapeutics’ private placement fuels DNA-damage response therapies
Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company pioneering innovative cancer therapies through advancements in DNA-damage response technologies,…